A detailed history of Somerville Kurt F transactions in Merck & Co., Inc. stock. As of the latest transaction made, Somerville Kurt F holds 20,831 shares of MRK stock, worth $2.12 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
20,831
Previous 20,881 0.24%
Holding current value
$2.12 Million
Previous $2.76 Million 6.42%
% of portfolio
0.44%
Previous 0.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $6,190 - $6,648
-50 Reduced 0.24%
20,831 $2.58 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $61,715 - $71,912
-545 Reduced 2.54%
20,881 $2.76 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $2,504 - $2,725
-25 Reduced 0.12%
21,426 $2.34 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $146,909 - $163,148
-1,427 Reduced 6.24%
21,451 $2.21 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $16,291 - $17,757
-150 Reduced 0.65%
22,878 $2.64 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $31,911 - $35,606
-310 Reduced 1.33%
23,028 $2.45 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $8,744 - $11,211
-100 Reduced 0.43%
23,338 $2.59 Million
Q3 2022

Nov 08, 2022

SELL
$84.53 - $94.96 $15,807 - $17,757
-187 Reduced 0.79%
23,438 $2.02 Million
Q2 2022

Jul 19, 2022

SELL
$83.49 - $94.64 $4,174 - $4,732
-50 Reduced 0.21%
23,625 $2.15 Million
Q1 2022

May 17, 2022

SELL
$73.51 - $82.4 $159,075 - $178,313
-2,164 Reduced 8.37%
23,675 $1.94 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $72,280 - $90,540
-1,000 Reduced 3.73%
25,839 $1.98 Million
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $21,093 - $23,331
-300 Reduced 1.11%
26,839 $2.09 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $24,514 - $28,875
356 Added 1.33%
27,139 $2.09 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $49,951 - $55,436
-696 Reduced 2.53%
26,783 $2.19 Million
Q3 2020

Oct 28, 2020

BUY
$73.18 - $82.95 $86,718 - $98,295
1,185 Added 4.51%
27,479 $2.28 Million
Q2 2020

Jul 28, 2020

SELL
$70.42 - $80.13 $17,464 - $19,872
-248 Reduced 0.93%
26,294 $2.03 Million
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $418,936 - $580,665
6,612 Added 33.18%
26,542 $2.04 Million
Q4 2019

Jan 15, 2020

SELL
$77.58 - $87.54 $43,134 - $48,672
-556 Reduced 2.71%
19,930 $1.81 Million
Q3 2019

Nov 06, 2019

SELL
$76.08 - $82.93 $38,040 - $41,465
-500 Reduced 2.38%
20,486 $1.73 Million
Q2 2019

Jul 24, 2019

SELL
$69.84 - $81.59 $117,680 - $137,479
-1,685 Reduced 7.43%
20,986 $1.76 Million
Q1 2019

May 01, 2019

SELL
$69.58 - $79.36 $335,932 - $383,150
-4,828 Reduced 17.56%
22,671 $1.89 Million
Q4 2018

Jan 24, 2019

SELL
$65.24 - $75.71 $94,597 - $109,779
-1,450 Reduced 5.01%
27,499 $2.1 Million
Q3 2018

Oct 15, 2018

SELL
$57.69 - $67.84 $69,401 - $81,611
-1,203 Reduced 3.99%
28,949 $2.05 Million
Q2 2018

Jul 30, 2018

SELL
$50.83 - $59.72 $98,966 - $116,274
-1,947 Reduced 6.07%
30,152 $1.83 Million
Q1 2018

Apr 24, 2018

SELL
$50.96 - $59.23 $220,911 - $256,762
-4,335 Reduced 11.9%
32,099 $1.75 Million
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $235,129 - $280,770
4,555 Added 14.29%
36,434 $2.05 Million
Q3 2017

Oct 26, 2017

BUY
$58.67 - $63.13 $1.87 Million - $2.01 Million
31,879
31,879 $2.04 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Somerville Kurt F Portfolio

Follow Somerville Kurt F and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.